1Bonds DE, Miller ME, Bergenstal RM,et al. The associationbetween sywptomatic,serere hypoglycaemiaand mortality in type2 diaretes : retrospective epidemiological analysis of the ACCORDstudy. BMJ 2010 ;340 :64909.
2UK Prospective Diabotes Study ( UKPDS ) Group. Intensiveblood-glucose control with sulphonylureas or insulin compared withconventional treatment and risk of complica tions in patients with type2diabetes(UKPDS33). Lancet 1998;352:837-853.
3Gerstein HC,Miller ME,Byington RP,et al. Effects of inten-rite glucose lowering in.
4Del Pratos,lasalle J,Matthaei S,et al. Tailoring treatment tothe individual in typez diabetes practical guidance from the Global Part-nership for Effective Diabetetes Management,Tat J Glin Pract 2010;64:295-304.
5Duckworth W, Abraira C,Moritz T,et al. Glucose control andVascular complications in reterans with type 2 diabetes. Eng J Med2009;360:120-139.
6Bailey CJ,Blonde L,Dd Prato S,et al. what are the practicalimplications for treating diabetes in light of recent evidence? Vpdatedrecommendations from the Global Partnership for Effectire DiabetesManagement. Diab Vase Dis Res 2009 ;6 ;283-287.
7Aschner PJ and Ruiz AJ. Metabolic memory for vasculardis-ease in diabetes. Diabotes technol ther 2012;14(suppll) :68-74.
8Duckworth W, Abraira C, Morit Z T, et al. Glucose controland vascular complications in veterans with type 2 diabetes. N Engl JMed 2009;8:129-139.
9Bonds DE, Miller ME, Bergenstal RM, et al. The associationbetween symptomatic,severe hypoglycaemiaand mortality in type 2 di-abetes :retrospective epidemiological analysis of the ACCORD study.BMJ 2010;304:b4909.
10Ray KK, Seshasai SPK, Wijesuriya, et al. Effect of intensivecontrol of glucose on cardiovascular outcomes and death in patientswith diabetesja meta-analysis of randomised controlled trials, lanoet2009;373;1765-1772.
